Related references
Note: Only part of the references are listed.Hepatoprotective effects and structure-activity relationship of five flavonoids against lipopolysaccharide/D-galactosamine induced acute liver failure in mice
Yutong He et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2019)
PPAR-γ Activation Exerts an Anti-inflammatory Effect by Suppressing the NLRP3 Inflammasome in Spinal Cord-Derived Neurons
Qing-Qi Meng et al.
MEDIATORS OF INFLAMMATION (2019)
Advances in the physiology of gastric emptying
Raj K. Goyal et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2019)
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Catalytic receptors
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein-coupled receptors
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Nuclear hormone receptors
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Enzymes
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY
Simon D. Harding et al.
NUCLEIC ACIDS RESEARCH (2018)
Goals and practicalities of immunoblotting and immunohistochemistry: A guide for submission to the British Journal of Pharmacology
Steve P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers
Michael J. Curtis et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Anti-inflammatory effects of luteolin: A review of in vitro, in vivo, and in silico studies
Nur Aziz et al.
JOURNAL OF ETHNOPHARMACOLOGY (2018)
Peroxisome Proliferator Activated Receptor gamma (PPAR gamma) Agonist Rosiglitazone Ameliorate Airway Inflammation by Inhibiting Toll-Like Receptor 2 (TLR2)/Nod-Like Receptor with Pyrin Domain Containing 3 (NLRP3) Inflammatory Corpuscle Activation in Asthmatic Mice
Yinzhi Cheng et al.
MEDICAL SCIENCE MONITOR (2018)
Evaluation of Anti-Nociceptive and Anti-Inflammatory Effect of Luteolin in Mice
Xiaoying Fan et al.
JOURNAL OF ENVIRONMENTAL PATHOLOGY TOXICOLOGY AND ONCOLOGY (2018)
Diuretic and natriuretic effect of luteolin in normotensive and hypertensive rats: Role of muscarinic acetylcholine receptors
Thaise Boeing et al.
PHARMACOLOGICAL REPORTS (2017)
Luteolin suppresses the JAK/STAT pathway in a cellular model of intestinal inflammation
Carla Nunes et al.
FOOD & FUNCTION (2017)
New Frontiers in the Pathobiology and Treatment of Cancer Regimen-Related Mucosal Injury
Marika Cinausero et al.
FRONTIERS IN PHARMACOLOGY (2017)
Macrophage alternative activation confers protection against lipotoxicity-induced cell death
Lingling Dai et al.
MOLECULAR METABOLISM (2017)
Diuretic, natriuretic and potassium-sparing effect of nothofagin isolated from Leandra dasytricha (A. Gray) Cogn. leaves in normotensive and hypertensive rats
Camila Leandra Bueno de Almeida et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2017)
Irinotecan- and 5-fluorouracil-induced intestinal mucositis: insights into pathogenesis and therapeutic perspectives
Ronaldo A. Ribeiro et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)
Luteolin ameliorates dextran sulfate sodium-induced colitis in mice possibly through activation of the Nrf2 signaling pathway
Yue Li et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2016)
Antiulcer mechanisms of Vernonia condensata Baker: A medicinal plant used in the treatment of gastritis and gastric ulcer
Thaise Boeing et al.
JOURNAL OF ETHNOPHARMACOLOGY (2016)
Irinotecan-Induced Gastrointestinal Dysfunction and Pain Are Mediated by Common TLR4-Dependent Mechanisms
Hannah R. Wardill et al.
MOLECULAR CANCER THERAPEUTICS (2016)
The reduction of oxidative stress by nanocomposite Fullerol decreases mucositis severity and reverts leukopenia induced by Irinotecan
Raquel Duque Nascimento Arifa et al.
PHARMACOLOGICAL RESEARCH (2016)
Attenuation effect of Abnormal Savda Munziq on liver and heart toxicity caused by chemotherapy in mice
Ainiwaer Aikemu et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2016)
Luteolin as an anti-inflammatory and neuroprotective agent: A brief review
Seyed Fazel Nabavi et al.
BRAIN RESEARCH BULLETIN (2015)
Dark Agouti rat model of chemotherapy-induced mucositis: Establishment and current state of the art
Barbara Vanhoecke et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2015)
Isolation of Luteolin and Luteolin-7-O-glucoside from Dendranthema morifolium Ramat Tzvel and Their Pharmacokinetics in Rats
Lie-Chwen Lin et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2015)
CPT-11 activates NLRP3 inflammasome through JNK and NF-κB signalings
Qian Li et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2015)
Irinotecan, a key chemotherapeutic drug for metastatic colorectal cancer
Ken-ichi Fujita et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Inflammasome Activation Is Reactive Oxygen Species Dependent and Mediates Irinotecan-Induced Mucositis through IL-1β and IL-18 in Mice
Raquel D. N. Arifa et al.
AMERICAN JOURNAL OF PATHOLOGY (2014)
Luteolin, a Bioflavonoid Inhibits Colorectal Cancer through Modulation of Multiple Signaling Pathways: A Review
Ashok Kumar Pandurangan et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Irinotecan disrupts tight junction proteins within the gut Implications for chemotherapy-induced gut toxicity
Hannah R. Wardill et al.
CANCER BIOLOGY & THERAPY (2014)
Luteolin Alleviates Alcoholic Liver Disease Induced by Chronic and Binge Ethanol Feeding in Mice
Gaigai Liu et al.
JOURNAL OF NUTRITION (2014)
Guidance on the management of diarrhoea during cancer chemotherapy
Jervoise Andreyev et al.
LANCET ONCOLOGY (2014)
IL-33 targeting attenuates intestinal mucositis and enhances effective tumor chemotherapy in mice
R. Guabiraba et al.
MUCOSAL IMMUNOLOGY (2014)
Intestinal anti-inflammatory activity of luteolin: role of the aglycone in NF-κB inactivation in macrophages co-cultured with intestinal epithelial cells
Yosuke Nishitani et al.
BIOFACTORS (2013)
Regulation of intestinal epithelial permeability by tight junctions
Takuya Suzuki
CELLULAR AND MOLECULAR LIFE SCIENCES (2013)
Chemotherapy-Induced Hepatotoxicity
Ameet V. Thatishetty et al.
CLINICS IN LIVER DISEASE (2013)
Combined antihypertensive effect of luteolin and buddleoside enriched extracts in spontaneously hypertensive rats
Gui-Yuan Lv et al.
JOURNAL OF ETHNOPHARMACOLOGY (2013)
Anti-diabetic properties of flavonoid compounds isolated from Hyphaene thebaica epicarp on alloxan induced diabetic rats
Josline Y. Salib et al.
PHARMACOGNOSY RESEARCH (2013)
Involvement of nitric oxide on the pathogenesis of irinotecan-induced intestinal mucositis: role of cytokines on inducible nitric oxide synthase activation
Roberto Cesar P. Lima-Junior et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2012)
Chemotherapy-induced gut toxicity: are alterations to intestinal tight junctions pivotal?
Hannah R. Wardill et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2012)
Occludin: One Protein, Many Forms
Philip M. Cummins
MOLECULAR AND CELLULAR BIOLOGY (2012)
Mode of Peroxisome Proliferator-Activated Receptor γ Activation by Luteolin
Ana C. Puhl et al.
MOLECULAR PHARMACOLOGY (2012)
Animal research: Reporting in vivo experiments: The ARRIVE guidelines
Carol Kilkenny et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
STAT6 Transcription Factor Is a Facilitator of the Nuclear Receptor PPARγ-Regulated Gene Expression in Macrophages and Dendritic Cells
Attila Szanto et al.
IMMUNITY (2010)
Zonula Occludens-1 and-2 Are Cytosolic Scaffolds That Regulate the Assembly of Cellular Junctions
Alan S. Fanning et al.
MOLECULAR STRUCTURE AND FUNCTION OF THE TIGHT JUNCTION: FROM BASIC MECHANISMS TO CLINICAL MANIFESTATIONS (2009)
Irinotecan-induced mucositis is associated with changes in intestinal mucins
Andrea M. Stringer et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
Review: Chemotherapy-induced diarrhea: pathophysiology, frequency and guideline-based management
Alexander Stein et al.
Therapeutic Advances in Medical Oncology (2009)
Gastrointestinal dysmotility in 5-fluorouracil-induced intestinal mucositis outlasts inflammatory process resolution
Pedro M. G. Soares et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
Evaluation and management of treatment-related diarrhea in patients with advanced cancer: A review
Nathan I. Cherny
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2008)
Anti-Oxidant, Anti-inflammatory and Anti-Allergic Activities of Luteolin
Guenter Seelinger et al.
PLANTA MEDICA (2008)
Characterisation of mucosal changes in the alimentary tract following administration of irinotecan: implications for the pathobiology of mucositis
Richard M. Logan et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
PPARs and molecular mechanisms of transrepression
Mercedes Ricote et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2007)
Role of p53 in irinotecan-induced intestinal cell death and mucosal damage
Joanne M. Bowen et al.
ANTI-CANCER DRUGS (2007)
Society of toxicologic pathology position paper: Organ weight recommendations for toxicology studies
Rani S. Sellers et al.
TOXICOLOGIC PATHOLOGY (2007)
The flavonoid luteolin prevents lipopolysaccharide-induced NF-κB signalling and gene expression by blocking IκB kinase activity in intestinal epithelial cells and bone-marrow derived dendritic cells
JS Kim et al.
IMMUNOLOGY (2005)
Mucin dynamics in the chick small intestine are altered by starvation
A Smirnov et al.
JOURNAL OF NUTRITION (2004)
The interplay of glutathione-related processes in antioxidant defense
NHP Cnubben et al.
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY (2001)
Share Paper
